Home/Filings/4/0001209191-23-033573
4//SEC Filing

LEE WILLIS C 4

Accession 0001209191-23-033573

CIK 0000822370other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 1:23 PM ET

Size

7.8 KB

Accession

0001209191-23-033573

Insider Transaction Report

Form 4
Period: 2022-09-20
LEE WILLIS C
DirectorVice Chairman & COO
Transactions
  • Purchase

    Common stock, $0.001 par value

    2022-09-20$0.28/sh+750$210287,724 total
  • Purchase

    Common stock, $0.001 par value

    2023-05-31$0.29/sh+28,700$8,32330,600 total(indirect: By IRA)
Holdings
  • Common stock, $0.001 par value

    (indirect: By IRA)
    241,194
Footnotes (1)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.28 to $0.32, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

Issuer

Emmaus Life Sciences, Inc.

CIK 0000822370

Entity typeother

Related Parties

1
  • filerCIK 0001517775

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 1:23 PM ET
Size
7.8 KB